BACKGROUND: Hematopoietic stem cell transplantation (HCT) may result in important disease- and treatment-related late effects. This study estimated physical, emotional, and educational limitations (performance limitations) and restrictions in the ability to perform personal care or routine daily activities (physical participation restrictions) and restrictions in the ability to participate in social roles (social participation restrictions) in a cohort of cancer survivors treated with HCT during childhood. METHODS: Study participants included 235 persons who had a malignancy or hematologic disorder, were treated with HCT before the age of 21 years, and survived at least 2 years after transplantation. A comparison group was recruited and frequency matched for age, sex, and ethnicity. Medical data were abstracted, and patients or parents (if <18 years at survey completion) completed a mailed 24-page questionnaire. RESULTS: Adult survivors of childhood cancer were more likely than the comparison group to report limitations in physical (prevalence odds ratio [OR], 2.2; 95% confidence interval [CI], 1.3-3.7) and emotional domains (OR, 2.9; 95% CI, 1.4-5.8) and to report physical participation restrictions (OR, 3.9; 95% CI, 1.9-8.2). Adult survivors were also less likely than the comparison group to be married (OR, 0.4; 95% CI, 0.2-0.6). Child survivors were more likely than similarly aged children to have participated in special education (OR, 3.0; 95% CI, 1.5-6.0), to report physical participation restrictions (OR, 10.8; 95% CI, 2.2-53.9), and to have behaviors that indicated impaired social competence (OR, 2.0; 95% CI, 0.9-4.2). CONCLUSION: This study demonstrated that persons treated with HCT as children were at increased risk for performance limitations that restricted participation in routine daily activities and interpersonal relationships.
BACKGROUND: Hematopoietic stem cell transplantation (HCT) may result in important disease- and treatment-related late effects. This study estimated physical, emotional, and educational limitations (performance limitations) and restrictions in the ability to perform personal care or routine daily activities (physical participation restrictions) and restrictions in the ability to participate in social roles (social participation restrictions) in a cohort of cancer survivors treated with HCT during childhood. METHODS: Study participants included 235 persons who had a malignancy or hematologic disorder, were treated with HCT before the age of 21 years, and survived at least 2 years after transplantation. A comparison group was recruited and frequency matched for age, sex, and ethnicity. Medical data were abstracted, and patients or parents (if <18 years at survey completion) completed a mailed 24-page questionnaire. RESULTS: Adult survivors of childhood cancer were more likely than the comparison group to report limitations in physical (prevalence odds ratio [OR], 2.2; 95% confidence interval [CI], 1.3-3.7) and emotional domains (OR, 2.9; 95% CI, 1.4-5.8) and to report physical participation restrictions (OR, 3.9; 95% CI, 1.9-8.2). Adult survivors were also less likely than the comparison group to be married (OR, 0.4; 95% CI, 0.2-0.6). Child survivors were more likely than similarly aged children to have participated in special education (OR, 3.0; 95% CI, 1.5-6.0), to report physical participation restrictions (OR, 10.8; 95% CI, 2.2-53.9), and to have behaviors that indicated impaired social competence (OR, 2.0; 95% CI, 0.9-4.2). CONCLUSION: This study demonstrated that persons treated with HCT as children were at increased risk for performance limitations that restricted participation in routine daily activities and interpersonal relationships.
Authors: K Scott Baker; Eric J Chow; Pamela J Goodman; Wendy M Leisenring; Andrew C Dietz; Joanna L Perkins; Lisa Chow; Alan Sinaiko; Antoinette Moran; Anna Petryk; Julia Steinberger Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-05 Impact factor: 4.254
Authors: Katarzyna Ibanez; Noel Espiritu; Regine L Souverain; Laura Stimler; Lauren Ward; Elyn R Riedel; Rachel Lehrman; Farid Boulad; Michael Dean Stubblefield Journal: Arch Phys Med Rehabil Date: 2017-08-12 Impact factor: 3.966
Authors: G Gifford; N Gilroy; G Dyer; L Brice; M Kabir; M Greenwood; S Larsen; J Moore; D Gottlieb; M Hertzberg; J Kwan; G Huang; J Tan; L Brown; M Hogg; C Ward; I Kerridge Journal: Bone Marrow Transplant Date: 2016-05-23 Impact factor: 5.483
Authors: Susan K Parsons; Sean Phipps; Lillian Sung; K Scott Baker; Michael A Pulsipher; Kirsten K Ness Journal: Biol Blood Marrow Transplant Date: 2011-12-10 Impact factor: 5.742
Authors: Kirsten K Ness; E Brannon Morris; Vikki G Nolan; Carrie R Howell; Laura S Gilchrist; Marilyn Stovall; Cheryl L Cox; James L Klosky; Amar Gajjar; Joseph P Neglia Journal: Cancer Date: 2010-06-15 Impact factor: 6.860
Authors: Amy G Feldman; Katie Neighbors; Shubhra Mukherjee; Melanie Rak; James W Varni; Estella M Alonso Journal: Liver Transpl Date: 2016-04 Impact factor: 5.799
Authors: Paul Grossman; Diana Zwahlen; Jorg P Halter; Jakob R Passweg; Claudia Steiner; Alexander Kiss Journal: Support Care Cancer Date: 2014-10-10 Impact factor: 3.603
Authors: J E Sanders; P A Hoffmeister; B E Storer; F R Appelbaum; R F Storb; K L Syrjala Journal: Bone Marrow Transplant Date: 2009-08-31 Impact factor: 5.483